PRAC Wants HES Infusion Solutions Off the Market in Europe

The European Medicines Agency’s committee says restrictions on HES infusion solutions introduced in 2013 to protect patients have not been sufficiently effective.
News Alerts

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply